Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Peringkat dalam Saham #30251
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Harga Saham
$1.88
Terakhir disinkronkan: 2026-08-18
Kapitalisasi Pasar
$17.59M
Perubahan (1 hari)
0.81%
Perubahan (1 tahun)
-92.40%
Negara
US
Perdagangan Tvardi Therapeutics, Inc. (TVRD)

Kategori

Riwayat harga saham Tvardi Therapeutics, Inc. (TVRD)
Harga penutupan tertinggi: $1.83 pada 2026-08-01

Harga penutupan terendah: $17.54 pada 2025-04-01
Riwayat harga saham Tvardi Therapeutics, Inc. dari 2025 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 100.99%
2025 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$730.65 5.32%
CH
$1.07K -5.58%
KR